Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IFIH1 antibody

This Rabbit Polyclonal antibody specifically detects IFIH1 in WB and IHC. It exhibits reactivity toward Mouse.
Catalog No. ABIN7566427

Quick Overview for IFIH1 antibody (ABIN7566427)

Target

See all IFIH1 Antibodies
IFIH1 (Interferon Induced with Helicase C Domain 1 (IFIH1))

Reactivity

  • 45
  • 13
  • 4
  • 2
  • 2
  • 2
  • 1
Mouse

Host

  • 37
  • 8
  • 2
Rabbit

Clonality

  • 36
  • 11
Polyclonal

Conjugate

  • 41
  • 3
  • 2
  • 1
This IFIH1 antibody is un-conjugated

Application

  • 37
  • 23
  • 22
  • 12
  • 8
  • 7
  • 7
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Purpose

    anti-MDA5 (mouse), pAb (AL180)

    Characteristics

    Polyclonal Antibody. Recognizes mouse MDA5. Source: Rabbit. Applications: IHC, WB. Liquid. In PBS containing 0.02 % sodium azide. RIG-I and MDA5 are highly conserved helicases involved in the innate immune response to virus. MDA5, upon interaction with intracellular dsRNA (produced during viral replication), triggers a transduction cascade involving MAVS/IPS1, which results in the activation of NF-kappaB, IRF3 and IRF7 and the induction of the expression of antiviral cytokines such as IFN-beta and RANTES (CCL5). MDA5 is widely expressed at low levels. The expression is detected at higher levels in placenta, pancreas and spleen and barely in brain, testis and lung. Genetic variation in MDA5 is associated with diabetes mellitus insulin-dependent type 19 (IDDM19). A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy.

    RIG-I and MDA5 are highly conserved helicases involved in the innate immune response to virus. MDA5, upon interaction with intracellular dsRNA (produced during viral replication), triggers a transduction cascade involving MAVS/IPS1, which results in the activation of NF-kappaB, IRF3 and IRF7 and the induction of the expression of antiviral cytokines such as IFN-beta and RANTES (CCL5). MDA5 is widely expressed at low levels. The expression is detected at higher levels in placenta, pancreas and spleen and barely in brain, testis and lung. Genetic variation in MDA5 is associated with diabetes mellitus insulin-dependent type 19 (IDDM19). A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy.

    Purification

    Puified

    Purity

    >95 % (SDS-PAGE)

    Immunogen

    Recombinant mouse MDA5 (aa 2-208).
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    In PBS containing 0.02 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Avoid freeze/thaw cycles.

    Storage

    4 °C,-20 °C

    Storage Comment

    +4°C

    Stable for at least 1 year after receipt when stored at -20°C.

  • Target

    IFIH1 (Interferon Induced with Helicase C Domain 1 (IFIH1))

    Alternative Name

    MDA5

    UniProt

    Q8R5F7

    Pathways

    Activation of Innate immune Response
You are here:
Chat with us!